Issue 2/2013

Expression of NRF2 and NRF2-modulated genes in peripheral blood leukocytes of bladder cancer males (123 — 128)

E. RESZKA, Z. JABLONOWSKI, E. WIECZOREK, J. GROMADZINSKA, E. JABLONSKA, M. SOSNOWSKI, W. WASOWICZ

DOI: 10.4149/neo_2013_016

Second line treatment in advanced non-small cell lung cancer (NSCLC): Comparison of efficacy of Erlotinib and chemotherapy (129 — 134)

O. FIALA, M. PESEK, J. FINEK, J. KREJCI, Z. BORTLICEK, L. BENESOVA, M. MINARIK

DOI: 10.4149/neo_2013_017

Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma (135 — 142)

J. QI, J. WANG, H. KATAYAMA, S. SEN, S. M. LIU

DOI: 10.4149/neo_2013_018

Pathological implication and function of Bcl2-inhibitor of transcription in ovarian serous papillary adenocarcinomas (143 — 150)

W. HUA, S. MIAO, W. ZOU, H. YANG, B. L. CHEN

DOI: 10.4149/neo_2013_019

Clinical impact of PAI 1 4G/5G gene polymorphism in colorectal carcinoma patients (151 — 159)

J. HALAMKOVA, I. KISS, Z. PAVLOVSKY, J. TOMASEK, J. JARKOVSKY, Z. CECH, D. BEDNAROVA, S. TUCEK, L. HANAKOVA, M. MOULIS, J. ZAVRELOVA, M. MAN, P. BENDA, O. ROBEK, Z. KALA, M. PENKA

DOI: 10.4149/neo_2013_020

Accelerated treatment of postpneumonectomy empyema – report of 12-year experience (160 — 166)

J. WOJCIK, T. GRODZKI, B. KUBISA, J. PIEROG, K. SAFRANOW, G. NAPRAWA

DOI: 10.4149/neo_2013_021

Is there still a role for autologous stem cell transplantation in acute myeloid leukemia? (167 — 173)

F. A. SABTY, E. DEMECKOVA, E. BOJTAROVA, M. HRUBISKO, M. MISTRIK

DOI: 10.4149/neo_2013_022

D2 lymphadenectomy can disseminate tumor cells into peritoneal cavity in patients with advanced gastric cancer (174 — 181)

X. F. YU, Z. G. REN, Y. W. XUE, H. T. SONG, Y. Z. WEI, C. M. LI

DOI: 10.4149/neo_2013_023

The relevance of monitoring of antibodies against the Polycyclic aromatic hydrocarbon (PAH) and PAH-DNA adducts in serum in relation to lung cancer and chronic obstructive pulmonary disease (COPD) (182 — 187)

N. PAUK, S. KLIMESOVA, J. KARA, J. TOPINKA, J. LABAJ

DOI: 10.4149/neo_2013_024

Mutational and expressional analysis of MLL genes in gastric and colorectal cancers with microsatellite instability (188 — 195)

E. M. JE, S. H. LEE, N. J. YOO, S. H. LEE

DOI: 10.4149/neo_2013_025

RKIP inhibits the malignant phenotypes of gastric cancer cells (196 — 202)

X. M. ZHANG, H. GU, L. YAN, G. Y. ZHANG

DOI: 10.4149/neo_2013_026

Preoperative platelet count in predicting lymph node metastasis and prognosis in patients with non-small cell lung cancer (203 — 208)

H. B. LIU, X. L. GU, X. Q. MA, T. F. LV, Y. WU, Y. Y. XIAO, D. M. YUAN, Y. F. LI, Y. SONG

DOI: 10.4149/neo_2013_027

The applicability of Ki-67 marker for renal epithelioid angiomyolipoma: experience of ten cases from a single center (209 — 214)

C. XU, X. Z. JIANG, H. F. ZHAO, N. Z. ZHANG, L. MA, Z. S. XU

DOI: 10.4149/neo_2013_028

Invasive Neuroendocrine Carcinoma of the Breast: A Prognostic Research of 107 Chinese Patients (215 — 222)

Y. ZHANG, Z. CHEN, Y. BAO, Z. DU, Q. LI, Y. ZHAO, F. TANG

DOI: 10.4149/neo_2013_029

Multi-level disruption of the extrinsic apoptotic pathway mediates resistance of leukemia cells to TNF-related apoptosis-inducing ligand (TRAIL) (223 — 231)

S. LEAHOMSCHI, J. MOLINSKY, M. KLANOVA, L. ANDERA, M. PETERKA, Z. GASOVA, P. KLENER SR., M. TRNENY, E. NECAS, T. SIMONOVA, J. ZIVNY, P. KLENER JR.

DOI: 10.4149/neo_2013_030